Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Medical Center Drive
Dartmouthhitchcock Medical Center GYN Oncology
Lebanon, NH 03756Phone+1 603-653-3525Fax+1 603-653-3545
Summary
- Dr. Evelyn Fleming is a gynecologic oncologist in Lebanon, NH and is affiliated with multiple hospitals in the area, including Cheshire Medical Center, Dartmouth-Hitchcock Medical Center, and the Catholic Medical Center. She received her medical degree from Dartmouth Medical School and has been in practice 16 years. She specializes in gynecologic oncology and hospice & palliative medicine.
Education & Training
- Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2005 - 2008
- Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2001 - 2005
- Geisel School of Medicine at DartmouthClass of 2001
Certifications & Licensure
- NH State Medical License 2008 - 2026
- VT State Medical License 2022 - 2026
- MT State Medical License 2023 - 2025
- WY State Medical License 2023 - 2025
- MA State Medical License 2006 - 2009
- RI State Medical License 2004 - 2005
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctor, NH magazine 2017-2020
- Top doctor NH magazine, 2017-2018
- National Faculty Award for excellence in residency teaching The council on resident education in obstetrics and gynecology, 2014
- Join now to see all
Clinical Trials
- A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) Start of enrollment: 2017 Dec 19
- Ribociclib and Letrozole Treatment in Ovarian Cancer Start of enrollment: 2018 Dec 14
Publications & Presentations
PubMed
- Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled...Annika Auranen, Matthew A Powell, Vladyslav Sukhin, Lisa M Landrum, Graziana Ronzino
Therapeutic Advances in Medical Oncology. 2024-01-01 - 31 citationsOVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with be...Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming
Gynecologic Oncology. 2022-08-01 - 75 citationsPhase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.Jonathan Oh, Minal A. Barve, Carolyn M. Matthews, E. Colin Koon, Thomas P. Heffernan
Gynecologic Oncology. 2016-12-01
Press Mentions
- 5 Facts You Should Know About Gynecological CancersSeptember 30th, 2020
- The AMA Does Not Speak for UsDecember 9th, 2016
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: